Chinese Journal of Respiratory and Critical Care Medicine
Supervisor：Ministry of Education of the People's Republic of ChinaSponsor：West China Medical Center & West China Hospital, Sichuan University Editor-in-chief：LIN Jiangtao / LIU Chuntao Publishing period：
Monthly
ISSN：1671-6205CN：51-1631/R
Citation：陳虎, 陳亮, 楊健, 張鶴, 涂雄文, 程玉生, 陸志偉. 免疫正常宿主侵襲性氣管支氣管曲霉病一例. Chinese Journal of Respiratory and Critical Care Medicine, 2019, 18(6): 581-583. doi: 10.7507/1671-6205.201801005Copy
Copyright ? the editorial department of Chinese Journal of Respiratory and Critical Care Medicine of West China Medical Publisher. All rights reserved
1.
Patterson TF, Thompson GR, Denning DW, et al. Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis, 2016, 63(4): 433-442.
2.
Wu N, Huang Y, Li Q, et al. Isolated invasive Aspergillus tracheobronchitis: a clinical study of 19 cases. Clin Microbiol Infect, 2010, 16(6): 689-695.
3.
Temime J, Mallat J, Van Grunderbeeck N, et al. Fulminant invasive tracheobronchial aspergillosis. Am J Respir Crit Care Med, 2015, 191(7): 848-849.
4.
Fernández-Ruiz M, Silva JT, San-Juan R, et al. Aspergillus tracheobronchitis: report of 8 cases and review of the literature. Medicine (Baltimore), 2012, 91(5): 261-273.
5.
Hartemink KJ, Paul MA, Spijkstra JJ, et al. Immunoparalysis as a cause for invasive aspergillosis?. Intensive Care Med, 2003, 29(11): 2068-2071.
6.
Ramos A, Segovia, J, Gomez-Bueno M, et al. Pseudomembranous Aspergillus tracheobronchitis in a heart transplant recipient. Transpl Infect Dis, 2010, 12(1): 60-63.
7.
Aliyali M, Hedayat MT, Habibi MR, et al. Clinical risk factors and bronchoscopic features of invasive aspergillosis in intensive care unit patients. J Prev Med Hyg, 2013, 54(2): 80-82.
8.
De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis, 2008, 46(12): 1813-1821.
1. Patterson TF, Thompson GR, Denning DW, et al. Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis, 2016, 63(4): 433-442.
2. Wu N, Huang Y, Li Q, et al. Isolated invasive Aspergillus tracheobronchitis: a clinical study of 19 cases. Clin Microbiol Infect, 2010, 16(6): 689-695.
3. Temime J, Mallat J, Van Grunderbeeck N, et al. Fulminant invasive tracheobronchial aspergillosis. Am J Respir Crit Care Med, 2015, 191(7): 848-849.
4. Fernández-Ruiz M, Silva JT, San-Juan R, et al. Aspergillus tracheobronchitis: report of 8 cases and review of the literature. Medicine (Baltimore), 2012, 91(5): 261-273.
5. Hartemink KJ, Paul MA, Spijkstra JJ, et al. Immunoparalysis as a cause for invasive aspergillosis?. Intensive Care Med, 2003, 29(11): 2068-2071.
6. Ramos A, Segovia, J, Gomez-Bueno M, et al. Pseudomembranous Aspergillus tracheobronchitis in a heart transplant recipient. Transpl Infect Dis, 2010, 12(1): 60-63.
7. Aliyali M, Hedayat MT, Habibi MR, et al. Clinical risk factors and bronchoscopic features of invasive aspergillosis in intensive care unit patients. J Prev Med Hyg, 2013, 54(2): 80-82.
8. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis, 2008, 46(12): 1813-1821.
1/5
WeChat